Page 45 - Confidence Interval News Today

Achiko AG / Key word(s): Preliminary Results Achiko AG: Achiko completes initial shipment of AptameX, its progressive Covid-19 diagnostic test, to Indonesia, delivering 77% sensitivity at low viral loads 20-May-2021 The issuer is solely responsible for the content of this announcement.   Achiko completes initial shipment of AptameX, its progressive Covid-19 diagnostic test, to Indonesia, delivering 77% sensitivity at low viral loads - Pr...

Background Anemia is a global public health problem, particularly in developing countries. Assessing the geographic distributions and determinant factors is a key and crucial step in designing targeted prevention and intervention programmes to address anemia. Thus, the current study is aimed to assess the spatial distribution and determinant factors of anemia in Ethiopia among adults aged 15–59. Methods A secondary data analysis was done based on 2016 Ethiopian Demographic and Health Surveys ...

Objectives: To (a) compare palliative care needs of lung cancer patients on their final admission to community-based and inpatient palliative care services; and (b) explore whether and how these care needs affect their utilisation of different palliative care services in the last days of life. Methods: Descriptive study involving 17,816 lung cancer patients who received the last episode of palliative care from specialist services and died between 1 January 2013 and 31 December 2018. Results: Bot...

The important first step in the critical appraisal of a randomised trial is not an evaluation of the statistical analyses. The most important aspect to consider when reviewing a study of a new drug is the appropriateness and quality of the trial design and methods. The next most important aspect is the effect size of different treatments and its clinical significance. Rather than reporting statistical significance, studies should report the difference between treatments and its precision. Over-r...

POLITICO Get the New York Playbook PM newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. 04/13/2021 03:55 PM EDT The Johnson & Johnson Covid-19 vaccine was billed as a “game-changer” to rapidly inoculate New Yorkers and re...

Nearly a quarter of patients who received Opdivo plus chemotherapy showed no evidence of cancer cells in tissue removed during surgery vs. 2.2% of patients who received chemotherapy alone Opdivo- based therapies have now demonstrated positive results in Phase 3 trials in earlier stages of four different types of cancer: non-small cell lung cancer, esophagealgastroesophageal junction cancer, bladder cancer and … Nearly a quarter of patients who received Opdivo plus chemotherapy showed no e...

Sanofi: FDA approves Libtayo (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of =50% N=356 a 14 months Median (95% CI) b Based on stratified proportional hazards model An additional prespecified analysis was performed in 563 patients with proven PD-L1 expression of =50%, according to the FDA-approved assay, and is described in the updated labeling of the FDA-approved assay (and also recently published (https://www.sanofi.com/...

Kaleido Biosciences to Present at the Keystone Symposium “Harnessing the Microbiome for Disease Prevention and Therapy” Conference LEXINGTON, Mass., Jan. 20, 2021 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), today announced Johan van Hylckama Vlieg, Ph.D., Chief Scientific Officer, will present at the Keystone Symposium “Harnessing the Microbiome for Disease Prevention and Therapy” conference this afternoon at 12:15 p.m. MST. The presentation will provide an update on ...

More Years of Obesity Linked to Higher Risk of Diseases by Colleen Fleiss on  December 19, 2020 at 11:12 PM A greater obesity duration is found to be associated with worse values for all cardiometabolic disease factors, stated a new study published this week in PLOS Medicine by Tom Norris of Loughborough University, UK, and colleagues. People with obesity do not all share the same risk for the development of cardiometabolic disease risk factors. The duration a person has spe...

Medieval period the same temperature may have cooled. the roman warming period, zero a.d., were cool. if you go to the geologic history of the earth were in the 10% coldest period of earths history. 90% was colder today and didnt support ice on either pole. we have warmed, thats undisputable. has man contributed. the united nations says man is responsible for the majority of the warming, 95% confidence interval, a show of hands of selected activist authors, some of whom -- >> tucker: theyre maki...